Clinical trial
Impact of Individual Atrial Arrhythmia Substrate on the Outcome Following Radiofrequency-Guided Catheter Ablation for Atrial Fibrillation in Patients With Diabetes Mellitus
NCT05873920 is registered in ClinicalTrials.gov with Heart and Diabetes Center North-Rhine Westfalia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Individual Atrial Arrhythmia Substrate on the Outcome Following Radiofrequency-Guided Catheter Ablation for Atrial Fibrillation in Patients With Diabetes Mellitus
- Lead sponsor
- Heart and Diabetes Center North-Rhine Westfalia
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 9, 2023
- Completion date
- May 31, 2025
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.